Viewing StudyNCT00410033



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00410033
Status: COMPLETED
Last Update Posted: 2016-12-22
First Post: 2006-12-11

Brief Title: Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin
Sponsor: Novo Nordisk AS
Organization: Novo Nordisk AS

Organization Data

Organization: Novo Nordisk AS
Class: INDUSTRY
Study ID: ANA-1676
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novo Nordisk AS
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators